Welcome to The Pharmacogenomics Journal
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.
Free online issue
Volume 8, No 6
December 2008
ISSN: 1470-269X
EISSN: 1473-1150
Impact Factor 4.968*
16/205 in Pharmacology & Pharmacy
20/132 Genetics & Heredity
Editor:
Julio Licinio, MD
*2007 Journal Citation Report (Thomson Reuters, 2008)
FEATURED ARTICLES
REVIEW
History of abacavir hypersensitivity PGx FREEORIGINAL ARTICLE
Clomipramine reverses hippocampal cell proliferation FREEORIGINAL ARTICLE
-Receptor polymorphisms and response to dobutamine
FREE ORIGINAL ARTICLE
CYP3A5 and patient survival in kidney transplantation FREENEWS
Disease complexity and drug safety. Using Alzheimer's disease as a model of tackling complex pharmacogenetics issues, a review article by Roses et al. discusses how pharmacogenetics affects pipelines and phases of drug development.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Optically mediated particle clearing using Airy wavepackets Source: Nature Photonics
- Central blood pressure measurement may improve risk stratification - this content is FREE Source: Journal of Human Hypertension
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis - this content is FREE Source: Nature Clinical Practice Neurology